CN108743834A - It is a kind of to treat cirsoid capsule - Google Patents
It is a kind of to treat cirsoid capsule Download PDFInfo
- Publication number
- CN108743834A CN108743834A CN201810944448.7A CN201810944448A CN108743834A CN 108743834 A CN108743834 A CN 108743834A CN 201810944448 A CN201810944448 A CN 201810944448A CN 108743834 A CN108743834 A CN 108743834A
- Authority
- CN
- China
- Prior art keywords
- radix
- juice
- angelicae sinensis
- capsule
- ginkgo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
A kind of to treat cirsoid capsule, it is by following Raw material processing：Radix Notoginseng, Radix Angelicae Sinensis, safflower, pueraria lobata, ginkgo, Radix Astragali, wheat seeding juice, acetylsalicylic acid tablet, capsulae vacuus.The beneficial effects of the invention are as follows：（1）Start with from the pathogenic factor of patient, improve itself functional defect, and be aided with the drug dredged, to thoroughly solve the problems, such as patient's varication.（2）Uneasy to recur, safety is without side-effects.
Description
Technical field
The present invention relates to a kind of capsules, and in particular to a kind of to treat cirsoid capsule.
Background technology
Cirsoid true cause is that vein valve is impaired or thrombus, caused venous circulation are obstructed.Have plenty of because
It is weaker for congenital vascular wall film, it is having because overworked or standing for a long time, causes blood to accumulate lower limb, accumulated in day
In the case that the moon is tired, cause vein valve impaired, vein pressure is excessively high, and blood vessel will protrude skin surface, and increasingly severe.
Currently, many hospitals are all using the method for local Minimally Invasive Surgery, the varication of patient is quickly solved the problems, such as.Though
So, the symptom of patient can quickly be alleviated, and fundamentally cannot solve the problems, such as varication, it is easy to it recurs,
Serious spirit and financial burden are caused to patient.
Invention content
Cirsoid capsule is treated the object of the present invention is to provide a kind of, is started with from cirsoid Crack cause,
Itself functional defect is improved, and is aided with the drug dredged, to thoroughly solve the problems, such as varication, and cannot be had any
Side effect.
In order to achieve the above-mentioned object of the invention, technical solution provided by the invention is as follows：
A kind of to treat cirsoid capsule, it is by following Raw material processing：Radix Notoginseng, Radix Angelicae Sinensis, safflower, pueraria lobata, ginkgo, Huang
Stilbene, wheat seeding juice, acetylsalicylic acid tablet, capsulae vacuus.
Preferentially, the Radix Notoginseng, Radix Angelicae Sinensis, safflower, pueraria lobata, ginkgo, Radix Astragali are bought in Chinese medicine shop, it is desirable that deep
It is dry to go mouldy without miscellaneous nothing.
Preferentially, the wheat seeding juice is that wheat uses soilless culture method, seedling to reach a leaf wholeheartedly, root is gone to harvest,
Made of low speed juicer is squeezed the juice.
Preferentially, the acetylsalicylic acid tablet pulvis, is aspirin enteric coated tablet, and specification 100mg is manufactured after crushing
Pulvis
Preferentially, the capsulae vacuus, cap, body two made of Capsules add auxiliary material refined by pharmagel save capsule shells group
At specification is No. 1, opaque.
The beneficial effects of the invention are as follows：（1）Start with from the pathogenic factor of patient, improve itself functional defect, and be aided with thin
The drug led, to thoroughly solve the problems, such as patient's varication.
（2）Uneasy to recur, safety is without side-effects.
Specific implementation mode
A kind of to treat cirsoid capsule, it is by following Raw material processing：3 portions of Radix Notoginseng, 2 parts of Radix Angelicae Sinensis, 2 parts of safflowers, 1
Part pueraria lobata, 1.5 portions of ginkgoes, 3 parts of Radix Astragalis, 30 parts of wheat seeding juices, 0.5 part of acetylsalicylic acid tablet pulvis, several capsulae vacuus.
Preferably, 3 portions of Radix Notoginseng, 2 parts of Radix Angelicae Sinensis, 2 parts of safflowers, 1 part of pueraria lobata, 1.5 portions of ginkgoes, 3 parts of Radix Astragalis, be all
The purchase of Chinese medicine shop, it is desirable that deep do is gone mouldy without miscellaneous nothing.
Preferably, 30 parts of wheat seeding juices are that wheat uses soilless culture method, seedling to reach a leaf wholeheartedly, remove root
Harvest, made of low speed juicer is squeezed the juice.
Preferably, 0.5 part of acetylsalicylic acid tablet pulvis, is aspirin enteric coated tablet, and specification 100mg makes after crushing
At pulvis.
Preferably, several described capsulae vacuus, cap, body two made of Capsules add auxiliary material refined by pharmagel save
Capsule shells form, and specification is No. 1, opaque, and number is uncertain.
Preferably, 3 portions of Radix Notoginseng, 2 parts of Radix Angelicae Sinensis, 2 parts of safflowers, 1 part of pueraria lobata, 1.5 portions of ginkgoes, 3 parts of Radix Astragalis, with 60
The pure water of part impregnates 1.5 hours, is heated to boiling with high heat, then is heated 1.5 hours with slow boiling, ceases fire, is gone out with filtered through gauze
Soup naturally cools to room temperature.
Preferably, 0.5 part of acetylsalicylic acid tablet pulvis, is added in 30 parts of wheat seeding juices, stirs evenly.
Preferably, two kinds of liquid mix, stir evenly, after being dehydrated with low temperature vacuum drier, water
Divide and be less than 10%, you can is fitted into several described capsulae vacuus, is finished product.
Claims (8)
1. a kind for the treatment of cirsoid capsule, it is by following Raw material processing：Radix Notoginseng, Radix Angelicae Sinensis, safflower, pueraria lobata, ginkgo, Huang
Stilbene, wheat seeding juice, acetylsalicylic acid tablet, capsulae vacuus.
2. Radix Notoginseng, Radix Angelicae Sinensis, safflower described in, pueraria lobata, ginkgo, Radix Astragali are bought in Chinese medicine shop, it is desirable that deep dry without miscellaneous nothing
It goes mouldy.
3. wheat seeding juice described in is that wheat uses soilless culture method, and seedling reaches a leaf wholeheartedly, root is gone to harvest, using low speed
Made of juice extractor is squeezed the juice.
4. acetylsalicylic acid tablet pulvis described in is aspirin enteric coated tablet, specification 100mg, manufactured pulvis after crushing.
5. capsulae vacuus described in, cap, body two made of Capsules add auxiliary material refined by pharmagel save capsule shells and form, specification
It is No. 1, it is opaque.
6. preferably, the Radix Notoginseng, Radix Angelicae Sinensis, safflower, pueraria lobata, ginkgo, Radix Astragali are impregnated 1.5 hours, are useed force with pure water
Fire is heated to boiling, then is heated 1.5 hours with slow boiling, ceases fire, goes out soup with filtered through gauze, naturally cool to room temperature.
7. preferably, the acetylsalicylic acid tablet pulvis, is added in the wheat seeding juice, stirs evenly.
8. preferably, two kinds of liquid mix, stir evenly, after being dehydrated with low temperature vacuum drier, moisture
Less than 10%, you can be fitted into several described capsulae vacuus, be finished product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810944448.7A CN108743834A (en) | 2018-08-19 | 2018-08-19 | It is a kind of to treat cirsoid capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810944448.7A CN108743834A (en) | 2018-08-19 | 2018-08-19 | It is a kind of to treat cirsoid capsule |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108743834A true CN108743834A (en) | 2018-11-06 |
Family
ID=63966346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810944448.7A Withdrawn CN108743834A (en) | 2018-08-19 | 2018-08-19 | It is a kind of to treat cirsoid capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108743834A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2595441A (en) * | 2020-04-23 | 2021-12-01 | Wang Lulin | Bone-strengthening pill (BSP) as a dietary supplement to improve blood circulation and strengthen bone and muscle |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199642A (en) * | 2007-12-19 | 2008-06-18 | 于殿安 | Chinese medicine agent for treating lower limbs vein curves |
| CN106177135A (en) * | 2016-08-10 | 2016-12-07 | 徐柳 | One is used for treating cirsoid medicine and preparation method thereof, application |
-
2018
- 2018-08-19 CN CN201810944448.7A patent/CN108743834A/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199642A (en) * | 2007-12-19 | 2008-06-18 | 于殿安 | Chinese medicine agent for treating lower limbs vein curves |
| CN106177135A (en) * | 2016-08-10 | 2016-12-07 | 徐柳 | One is used for treating cirsoid medicine and preparation method thereof, application |
Non-Patent Citations (1)
| Title |
|---|
| 靳晓华等: "中医治疗下肢静脉曲张研究进展 ", 《中医药临床杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2595441A (en) * | 2020-04-23 | 2021-12-01 | Wang Lulin | Bone-strengthening pill (BSP) as a dietary supplement to improve blood circulation and strengthen bone and muscle |
| GB2595441B (en) * | 2020-04-23 | 2022-08-10 | Wang Lulin | Bone-Strengthening Pill (BSP) as a Dietary Supplement to Improve Blood Circulation and Strengthen Bone and Muscle |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102159227B (en) | Pharmaceutical composition for purifing vein and preparation method thereof | |
| CN105995720A (en) | Enzyme Laiyang pear paste and preparation method and application thereof | |
| CN102669348B (en) | Nutrition food of heart nourishing tea granule for nourishing heart | |
| CN104784473A (en) | Earthworm protein health care product | |
| CN104758806A (en) | Decocted extract for treating coronary heart disease and preparation method thereof | |
| CN102551061B (en) | Canarium album granule with hypolipidemic and hypoglycemic effects and preparation process of same | |
| CN108743834A (en) | It is a kind of to treat cirsoid capsule | |
| CN110368482A (en) | A kind of composition and its preparing the application in prevention and cure of cardiovascular disease drug | |
| CN102626162A (en) | Nutrition food heart-nourishing tea granule for nourishing hearts | |
| CN102823687A (en) | Health tea electuary for preventing blood fat abnormity | |
| CN105362394A (en) | Celery seed blood pressure and blood lipid reducing medicine and preparing method thereof | |
| CN105770798A (en) | Traditional Chinese medicine used for treating wind phlegm and blood stasis and meridian obstruction type cerebral infarction | |
| CN105232650B (en) | A kind of ointment that treating scald and its preparation and application | |
| CN103893327B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of hyperlipemia | |
| CN105687961A (en) | Preparation method of granule for treating coronary artery atherosclerosis | |
| CN117771198A (en) | Abelmoschus manihot compound heart nourishing pill and preparation method thereof | |
| CN107569565A (en) | A kind of Chinese medicinal lotion for treating tinea pedis and preparation method thereof | |
| CN102370817B (en) | Medicine decoction for treating light-headedness | |
| CN107198095A (en) | A kind of blood-nourishing hypotensive dietotherapy health-preserving porridge formula | |
| CN113519658A (en) | Health tea capable of reducing high blood pressure, high blood sugar and preparation method of health tea | |
| CN105641429A (en) | Rhaphidop hora hongkongensis shott blood circulation activation and blood stasis removing bath powder and production method thereof | |
| CN113476592A (en) | Medicinal liquor for balancing blood pressure, reducing uric acid and tonifying kidney | |
| CN104664348A (en) | Traditional Chinese medicine health product capable of improving atherosclerosis | |
| CN109602814A (en) | A kind of Tibetan medicinal composition and preparation method thereof for treating animal conjunctiva inflammation and keratitis | |
| CN109045161A (en) | A kind of Chinese medicine composition and preparation method thereof for treating heart and brain thrombus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20181106 |
|
| WW01 | Invention patent application withdrawn after publication |